Clearmind Medicine Inc (CMND) Company Profile & Statistics

Clearmind Medicine Inc
CMND
(Nasdaq - US)
Open
1.32
-0.02 (-1.49%)
in:usd•As of: Nov 18, 2024 15:10 UTC -5
Open
1.38
High
1.38
Low
1.32

About Clearmind Medicine Inc

CEO

Adi Zuloff-Shani

Headquarters

101-1220 west 6th avenue

vancouver, a1 v6h1a5, canada

Auditor

Brightman Almagor Zohar & Co.

Employees

N/A

Share Holders

N/A

Website

www.clearmindmedicine.com

Industry

other metals or minerals

Sector

non energy minerals

Company Overview

Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Clearmind Medicine Inc. is based in VANCOUVER.

Clearmind Medicine Inc Statistics

Valuation Measures

Market Capitalization ²	2.23M
Enterprise Value	-5.39M
Enterprise Value/EBITDA (ttm)	0.92
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.65
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-238.73%
Return on Invested Capital (ttm)	-520.19%
Return on Assets (ttm)	-102.10%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-5.86M
Net Income Avi to Common (ttm)	-8.44M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	1.26
52-Week Change	-63.03%
S&P500 52-Week Change	29.65%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	0.00
% Held by Insiders	N/A
% Held by Institutions	96.05%

Balance Sheet

Total Cash (mrq)	7.68M
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	60.90K
Total Debt/Equity (mrq)	1.75%
Current Ratio (mrq)	1.71%
Quick Ratio (mrq)	1.71%
Book Value Per Share (mrq)	0.87

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.06
Free Cash Flow (ytd)	-3.78M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Clearmind Medicine Inc

Trade With A Regulated Broker